RecruitingNCT06793163

Diagnosis and Allergen Identification of Perioperative Anaphylaxis

Diagnosis and Allergen Identification of Perioperative Anaphylaxis: a Multicenter Prospective Cohort Study

Sponsor

Peking University First Hospital

Enrollment

115 participants

Start Date

Jan 25, 2025

Study Type

OBSERVATIONAL

Conditions

Anaphylaxis Perioperative/Postoperative Complications Tryptase Allergens Skin Testing

Summary

Perioperative anaphylaxis may lead to fatal respiratory and/or circulatory events, yet both clinical diagnosis and management are challenging. Serum tryptase is an indicator that can provide important retrospective diagnostic value for anaphylaxis. Another key point in perioperative anaphylaxis management is to identify the allergens, and thus avoid re-exposure during later perioperative management. Skin testing is an important way to identify allergens.

Eligibility

Min Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with allergens, anaphylaxis, and other related conditions. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 2 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.